166 related articles for article (PubMed ID: 14675323)
1. Prognostic significance of c-erbB-2/HER2 expression in advanced uterine cervical carcinoma with para-aortic lymph node metastasis treated with radiation therapy.
Niibe Y; Nakano T; Ohno T; Suzuki Y; Oka K; Tsujii H
Int J Gynecol Cancer; 2003; 13(6):849-55. PubMed ID: 14675323
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors associated with radiotherapy for cervical cancer with computed tomography-detected para-aortic lymph node metastasis.
Wu SY; Huang EY; Chanchien CC; Lin H; Wang CJ; Sun LM; Chen HC; Fang FM; Hsu HC; Huang YJ
J Radiat Res; 2014 Jan; 55(1):129-38. PubMed ID: 23814113
[TBL] [Abstract][Full Text] [Related]
3. Cyclooxygenase-2 expression as a predictor of para-aortic lymph node recurrence in uterine cervical cancer.
Kim JS; Li S; Kim JM; Yeo SG; Kim KH; Cho MJ
Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1516-21. PubMed ID: 17919838
[TBL] [Abstract][Full Text] [Related]
4. Hyperfractionated radiotherapy with concurrent chemotherapy for para-aortic lymph node recurrence in carcinoma of the cervix.
Kim JS; Kim JS; Kim SY; Kim Ki; Cho MJ
Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1247-53. PubMed ID: 12654434
[TBL] [Abstract][Full Text] [Related]
5. Prediction model for para-aortic lymph node metastasis in patients with locally advanced cervical cancer.
Shim SH; Kim DY; Lee SJ; Kim SN; Kang SB; Lee SW; Park JY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
Gynecol Oncol; 2017 Jan; 144(1):40-45. PubMed ID: 27855989
[TBL] [Abstract][Full Text] [Related]
6. IMRT dose escalation for positive para-aortic lymph nodes in patients with locally advanced cervical cancer while reducing dose to bone marrow and other organs at risk.
Ahmed RS; Kim RY; Duan J; Meleth S; De Los Santos JF; Fiveash JB
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):505-12. PubMed ID: 15380585
[TBL] [Abstract][Full Text] [Related]
7. Altered expression of nm23-H1 and c-erbB-2 proteins have prognostic significance in adenocarcinoma but not in squamous cell carcinoma of the uterine cervix.
Mandai M; Konishi I; Koshiyama M; Komatsu T; Yamamoto S; Nanbu K; Mori T; Fukumoto M
Cancer; 1995 May; 75(10):2523-9. PubMed ID: 7736397
[TBL] [Abstract][Full Text] [Related]
8. Survival following extended field irradiation in carcinoma of cervix metastatic to para-aortic lymph nodes.
Stryker JA; Mortel R
Gynecol Oncol; 2000 Dec; 79(3):399-405. PubMed ID: 11104609
[TBL] [Abstract][Full Text] [Related]
9. How to predict para-aortic node involvement in advanced cervical cancer? Development of a predictive score. A FRANCOGYN study.
Nguyen-Xuan HT; Benoit L; Dabi Y; Touboul C; Raimond E; Ballester M; Bendifallah S; Collinet P; Kerbage Y; Ouldamer L; Bricou A; Lavoue V; Carcopino X; Huchon C
Eur J Surg Oncol; 2021 Nov; 47(11):2900-2906. PubMed ID: 34274203
[TBL] [Abstract][Full Text] [Related]
10. Multivariate analysis of para-aortic lymph node recurrence after definitive radiotherapy for stage IB-IVA squamous cell carcinoma of uterine cervix.
Huang EY; Wang CJ; Chen HC; Fang FM; Huang YJ; Wang CY; Hsu HC
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):834-42. PubMed ID: 18439764
[TBL] [Abstract][Full Text] [Related]
11. EGFR and HER2 expression in primary cervical cancers and corresponding lymph node metastases: implications for targeted radiotherapy.
Shen L; Shui Y; Wang X; Sheng L; Yang Z; Xue D; Wei Q
BMC Cancer; 2008 Aug; 8():232. PubMed ID: 18700025
[TBL] [Abstract][Full Text] [Related]
12. Maximum Standardized Uptake Value of Pelvic Lymph Nodes in [18F]-Fluorodeoxyglucose Positron Emission Tomography Is a Prognostic Factor for Para-Aortic Lymph Node Recurrence in Pelvic Node-Positive Cervical Cancer Treated With Definitive Chemoradiotherapy.
Kim DH; Kim WT; Bae JS; Ki YK; Park D; Suh DS; Kim KH; Lee JH; Lee JY; Jeon HS; Nam JH
Int J Gynecol Cancer; 2016 Sep; 26(7):1274-80. PubMed ID: 27465890
[TBL] [Abstract][Full Text] [Related]
13. Recurrent squamous cell carcinoma of cervix after definitive radiotherapy.
Hong JH; Tsai CS; Lai CH; Chang TC; Wang CC; Chou HH; Lee SP; Hsueh S
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):249-57. PubMed ID: 15337563
[TBL] [Abstract][Full Text] [Related]
14. Risk stratification for failure in patients with advanced cervical cancer after concurrent chemoradiotherapy: another way to optimise treatment results.
Liang JA; Chen SW; Chang WC; Hung YC; Yeh LS; Yang SN; Lin FJ
Clin Oncol (R Coll Radiol); 2008 Nov; 20(9):683-90. PubMed ID: 18676129
[TBL] [Abstract][Full Text] [Related]
15. A prospective randomized trial to study the impact of pretreatment FDG-PET for cervical cancer patients with MRI-detected positive pelvic but negative para-aortic lymphadenopathy.
Tsai CS; Lai CH; Chang TC; Yen TC; Ng KK; Hsueh S; Lee SP; Hong JH
Int J Radiat Oncol Biol Phys; 2010 Feb; 76(2):477-84. PubMed ID: 19464824
[TBL] [Abstract][Full Text] [Related]
16. Patterns of Recurrence in Node-Positive Cervical Cancer Patients Treated With Contemporary Chemoradiation and Dose Escalation: A Multi-Institutional Study.
Sethi R; Mayadev J; Sethi S; Rash D; Chen LM; Brooks R; Ueda S; Hsu IC
Pract Radiat Oncol; 2019 Mar; 9(2):e180-e186. PubMed ID: 30342181
[TBL] [Abstract][Full Text] [Related]
17. Lack of effect of tumor size on the prognosis of carcinoma of the uterine cervix Stage IB and IIA treated with preoperative irradiation and surgery.
Grigsby PW; Perez CA; Chao KS; Elbendary A; Herzog TJ; Rader JS; Mutch DG
Int J Radiat Oncol Biol Phys; 1999 Oct; 45(3):645-51. PubMed ID: 10524418
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors in patients with carcinoma of the uterine cervix treated with external beam irradiation and IR-192 high-dose-rate brachytherapy.
Kapp KS; Stuecklschweiger GF; Kapp DS; Poschauko J; Pickel H; Lahousen M; Hackl A
Int J Radiat Oncol Biol Phys; 1998 Oct; 42(3):531-40. PubMed ID: 9806511
[TBL] [Abstract][Full Text] [Related]
19. Histopathological prognostic factors predicting para-aortic lymph node metastasis in patients with endometrioid uterine cancer.
Karube Y; Fujimoto T; Takahashi O; Nanjyo H; Mizunuma H; Yaegashi N; Sugiyama T; Kurachi H; Sato A; Tanaka T
Gynecol Oncol; 2010 Aug; 118(2):151-4. PubMed ID: 20621776
[TBL] [Abstract][Full Text] [Related]
20. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.
Morris M; Eifel PJ; Lu J; Grigsby PW; Levenback C; Stevens RE; Rotman M; Gershenson DM; Mutch DG
N Engl J Med; 1999 Apr; 340(15):1137-43. PubMed ID: 10202164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
